Realcan Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 3/6
Realcan Pharmaceutical Group has a total shareholder equity of CN¥5.7B and total debt of CN¥5.1B, which brings its debt-to-equity ratio to 89.8%. Its total assets and total liabilities are CN¥15.6B and CN¥9.9B respectively.
Key information
89.8%
Debt to equity ratio
CN¥5.08b
Debt
Interest coverage ratio | n/a |
Cash | CN¥4.02b |
Equity | CN¥5.66b |
Total liabilities | CN¥9.90b |
Total assets | CN¥15.56b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002589's short term assets (CN¥10.5B) exceed its short term liabilities (CN¥9.6B).
Long Term Liabilities: 002589's short term assets (CN¥10.5B) exceed its long term liabilities (CN¥321.5M).
Debt to Equity History and Analysis
Debt Level: 002589's net debt to equity ratio (18.7%) is considered satisfactory.
Reducing Debt: 002589's debt to equity ratio has increased from 65.8% to 89.8% over the past 5 years.
Debt Coverage: 002589's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 002589's interest payments on its debt are well covered by EBIT.